Want to see VJET full AI Analyst Report?
Top Page
Flyte Aviation
(NYSE MKT:VJET)
Select Model
Select Model
Rating:41Neutral
Price Target:
$1.00
▲(376.19% Upside)
Action:Reiterated
Date:10/08/26
The score is held down primarily by very large operating losses and ongoing free-cash-flow burn, despite improving revenue traction and relatively modest leverage. Technicals add further pressure with a strong downtrend across moving averages and negative MACD; the corporate rebrand/reverse split is a modest positive but not enough to offset weak fundamentals.
Positive Factors
Revenue Growth
Sharp TTM revenue growth indicates improving commercial traction and expanding customer demand. The accompanying gross profit shows the offering can produce meaningful economics before overhead, creating a foundation for operating leverage if sales continue scaling over coming quarters.
Negative Factors
Severe Operating Losses
Losses remain vastly larger than the current revenue base, showing that operating expenses are not yet supported by commercial scale. Unless revenue growth materially outpaces spending, persistent negative margins can erode equity, constrain investment, and undermine the durability of the business model.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sharp TTM revenue growth indicates improving commercial traction and expanding customer demand. The accompanying gross profit shows the offering can produce meaningful economics before overhead, creating a foundation for operating leverage if sales continue scaling over coming quarters.
Read all positive factors
Flyte Aviation (VJET) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$2.12M
Dividend YieldN/A
Average Volume (3M)663.65K
Price to Earnings (P/E)―
Beta (1Y)0.69
Revenue Growth219.17%
EPS Growth90.58%
CountryUS
Employees17
SectorHealthcare
Sector Strength45
IndustryAirlines, Airports & Air Services
Share Statistics
EPS (TTM)-73.30
Shares Outstanding2,101,987
10 Day Avg. Volume1,680,599
30 Day Avg. Volume663,652
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.28
Price to Sales (P/S)2.41
P/FCF Ratio-0.24
Enterprise Value/Market Cap6.86
Enterprise Value/Revenue7.60
Enterprise Value/Gross Profit15.92
Enterprise Value/Ebitda-1.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-608
Revenue Forecast (FY)$10.20M
Flyte Aviation Business Overview & Revenue Model
Company Description
The company operates private aviation and cardiac electrophysiology businesses. Its aviation business provides short-haul private air travel using Cirrus Vision Jets and private-flight coordination services; its medical business develops technolog...
How the Company Makes Money
Catheter Precision primarily makes money by selling its electrophysiology mapping catheter products and related disposable components for use in hospital electrophysiology labs during arrhythmia mapping and ablation procedures. Revenue is generall...
Flyte Aviation Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
48
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Mar 2026 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.92M | 819.00K | 420.00K | 442.00K | 14.00K | 22.00K |
| Gross Profit | 914.00K | 756.00K | 378.00K | 412.00K | -147.00K | -1.54M |
| EBITDA | -12.01M | -17.11M | -11.30M | -15.11M | -22.37M | -25.68M |
| Net Income | -12.66M | -17.18M | -16.64M | -70.57M | -26.86M | -25.07M |
Balance Sheet | ||||||
| Total Assets | 36.87M | 15.86M | 27.77M | 30.74M | 16.84M | 21.04M |
| Cash, Cash Equivalents and Short-Term Investments | 1.84M | 88.00K | 2.87M | 3.56M | 15.86M | 15.04M |
| Total Debt | 3.32M | 3.85M | 1.79M | 372.00K | 0.00 | 2.26M |
| Total Liabilities | 19.73M | 9.21M | 16.01M | 9.54M | 7.58M | 7.37M |
| Stockholders Equity | 17.56M | 7.05M | 11.76M | 21.19M | 9.26M | 13.67M |
Cash Flow | ||||||
| Free Cash Flow | -9.42M | -8.31M | -9.34M | -20.70M | -22.59M | -27.89M |
| Operating Cash Flow | -9.31M | -8.30M | -9.27M | -20.62M | -22.57M | -27.63M |
| Investing Cash Flow | -1.96M | 167.00K | -67.00K | -61.00K | 21.00K | 3.80M |
| Financing Cash Flow | 11.08M | 5.34M | 8.65M | 8.39M | 23.36M | 14.96M |
Flyte Aviation Technical Analysis
Negative
0.21
Price Trends
1.99
Negative
5.10
Negative
9.83
Negative
Market Momentum
-0.30
Negative
28.49
Positive
11.44
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VJET, the sentiment is Negative. The current price of 0.21 is below the 20-day moving average (MA) of 1.46, below the 50-day MA of 1.99, and below the 200-day MA of 9.83, indicating a bearish trend. The MACD of -0.30 indicates Negative momentum. The RSI at 28.49 is Positive, neither overbought nor oversold. The STOCH value of 11.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VJET.
Flyte Aviation Risk Analysis
Flyte Aviation disclosed 40 risk factors in its most recent earnings report. Flyte Aviation reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Flyte Aviation Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $9.64M | -0.52 | -123.09% | ― | ― | 87.54% | |
47 Neutral | $14.73M | -1.02 | -816.25% | ― | -27.70% | 61.44% | |
45 Neutral | $21.51M | -0.17 | -33.51% | ― | -89.02% | -107.75% | |
43 Neutral | $2.46M | >-0.01 | -605.75% | ― | 8.36% | 88.88% | |
41 Neutral | $2.12M | -0.02 | -123.66% | ― | 219.17% | 90.58% |
* Healthcare Sector Average
VJET
Flyte Aviation
1.01
-24.79
-96.09%
NUWE
Nuwellis
0.68
-119.03
-99.44%
AEMD
Aethlon Medical
6.01
-27.74
-82.19%
PAVM
PAVmed
2.69
-13.97
-83.85%
HSCS
Heart Test Laboratories, Inc.
3.04
-0.54
-15.08%
Flyte Aviation Corporate Events
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Flyte Aviation Announces New Preferred Stock Financing
Neutral
Oct 9, 2026
On October 9, 2026, Flyte Aviation, Inc. secured commitments from certain existing investors to purchase 2,050 shares of its Series C-4 Convertible Preferred Stock for gross proceeds of $2.05 million, with closing expected on or about October 13, ...
Business Operations and StrategyDelistings and Listing ChangesStock Split
Flyte Aviation Rebrands and Executes Reverse Stock Split
Positive
Oct 5, 2026
On October 5, 2026, Flyte Aviation, Inc. completed a rebranding from Catheter Precision, Inc., changed its NYSE American ticker from VTAK to VJET, and effected a 1-for-10 reverse stock split, leaving about 2.1 million shares outstanding on a split...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.